home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9407f.zip
/
M9471083.TXT
< prev
next >
Wrap
Text File
|
1994-08-09
|
3KB
|
44 lines
Document 1083
DOCN M9471083
TI Results in adults with small noncleaved cell (SNCL) lymphoma treated
with a short duration. Intensive chemotherapy protocol also used in
pediatric patients (Meeting abstract).
DT 9409
AU Magrath IT; Adde M; Shad A; Wittes RE; Horak ID; NCI, Bethesda, MD
SO Proc Annu Meet Am Soc Clin Oncol; 13:A1252 1994. Unique Identifier :
AIDSLINE ICDB/94601248
AB We have treated 20 adult patients with SNCL (12 BL, 7 non-BL, and 1
indeterminate) with an intensive chemotherapy protocol. None of the
patients were infected with HIV. The protocol consisted of two regimens,
A and B. Regimen A included CTX, ADR, VCR, and high dose MTX, and
regimens B: IFOS, VP16 and high dose Ara-C. Two (alternating) cycles of
each regimen were given to high risk patients (15), and 3 cycles of
regimen A to low risk patients (5). Each cycle commenced as soon as
granulocytes recovered to 1000 per cu mm. The total duration of therapy
was 12-16 wk for high risk patients and 9-12 wk for low risk patients.
All patients received IT Ara-C and MTX. 6 patients were Stage I, 11
Stage III and 3 Stage IV according to the St. Jude classification used
for pediatric SNCL. The age range was 18 to 59 years (median, 25 years).
Low risk patients had a single extra-abdominal mass and an LDH less than
350. All other patients were considered high risk (mean LDH 954 iu/l). 5
patients are too early to evaluate at this time (less than 6 mo from the
start of therapy). All 15 evaluable patients achieved CR and remain in
CR with a median follow up of 24 mo (range 6-51 mo). Most patients are
already beyond the high risk period for relapse (within 10 months from
the start of treatment). Toxicity was no worse in adults than in
children; the durations of myelosuppression, incidence of sepsis and
mucositis were similar, although adults appeared to develop neuropathy
more often. The preliminary results of this study are excellent, even in
very high risk patients, and suggest that adults with SNCL have a
similar prognosis to children when treated with an appropriate,
intensive chemotherapy regimen.
DE Adolescence Adult Antineoplastic Agents, Combined/ADVERSE
EFFECTS/*THERAPEUTIC USE Dose-Response Relationship, Drug Drug
Administration Schedule Female Follow-Up Studies Human Lymphoma,
Small Noncleaved-Cell/MORTALITY/PATHOLOGY/*THERAPY Male Middle Age
Neoplasm Staging Survival Rate MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).